🔗 Share this article

An underground market for unlicensed slimming medications is being driven by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.

Experimental Drug Acquiring Traction Via Social Media

The experimental drug, which remains in clinical trials, is being promoted by online personalities for its supposed fat-burning effects. Followers are encouraged to message these profiles privately for source information, while also obtaining discount codes.

Thriving Trade on Messaging Platforms

Additionally, a robust market exists on Telegram, where communities with thousands of participants share comparison photos, injection guides and claims of next-day UK delivery. Sellers promote the substance there before redirecting customers to WhatsApp for purchases.

Learning About Retatrutide

This medication is an experimental injection developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could assist patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic.

Medical Professionals Express Worries

However, doctors and pharmacists have cautions that the distribution of what remains an unlicensed medication in the UK is worrisome and could result in users administering substances of uncertain source.

Some experts said the demand for retatrutide could be linked to the increasing cost of approved weight loss treatments such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unapproved medication that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Several influencers try to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still violate pharmaceutical, advertising, and consumer regulations, potentially leading to penalties, legal action or prison.

Service Response and Material Elimination

Based on the social media company, the platform has taken down violative material and banned associated keywords and search suggestions. The organization stated it was dedicated to keeping the service safe and allocating resources in enhancing compliance measures.

Digital Marketplace Activities

Investigations also discovered groups with up to 9,000 participants marketing retatrutide using the platform's integrated discovery tool, which operates like a public directory. Typing “retatrutide” immediately displays channels with thousands of users, filled with images of slimming results, positive reviews and detailed instructions for preparing or administering at home.

Within moments of joining one community, a vendor shared WhatsApp details, where the majority of purchases take place. The seller provided an guidebook and promised shipping within two days. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one inquired about body mass, health issues or previous experience.

Product Details and Pricing

Inside these groups, posts display black plastic packages with Royal Mail stickers, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at residence with purified liquid, or ready-to-use pens typically priced at £160 for 20 milligrams. When questioned how much time a injector should last, sellers give contradictory answers varying between a few weeks to “depends on your body”.

Service Moderation and Safety Actions

A representative for Telegram stated it actively monitored harmful material on its platform including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are administering substances they cannot confirm. Although the research behind this drug is sound, these digital products may not contain what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

A medical professional of an online medical service connected the increase in interest to current price rises for approved weight-loss drugs such as Mounjaro. “With prices rising, patients are using social media. But fake injections are highly risky. You cannot know what’s contained or whether the conditions they were made in was clean,” she said.

Her staff has already encountered patients harmed by self-injection from unconfirmed suppliers. “We recognize the disappointment, but buying from Telegram or communication platforms is taking chances with your health,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Position

A spokesperson from the pharmaceutical company stated the substance was in third stage research studies and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this time no one can sell [it] for human use,” they said, adding that any item “falsely representing itself as a company investigational substance not yet authorized … may expose patients to potentially serious health risks”.